Amiodarone

CHEMBL633 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
645.3 g/mol
LogP
7.6
Phase
4

This heart rhythm medication works by slowing electrical signals in the heart to treat serious irregular heartbeats, including atrial fibrillation. It is typically reserved for life-threatening arrhythmias because it can affect the thyroid, lungs, and liver with long-term use, requiring regular monitoring.

분자량

645.3000 g/mol

LogP

7.60

TPSA

42.70 Ų

리핀스키 5의 법칙

불통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1

InChI

InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3

Molecular Formula

C25H29I2NO3

HBD / HBA

- / 4

회전 가능 결합

11

무거운 원자

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This heart rhythm medication works by slowing electrical signals in the heart to treat serious irregular heartbeats, including atrial fibrillation. It is typically reserved for life-threatening arrhythmias because it can affect the thyroid, lungs, and liver with long-term use, requiring regular monitoring.

Yes, Amiodarone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL633. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2157. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.